Deruelle, Philippe <br/><br/>
BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.  [electronic resource] 

 -  Biology of the neonate  2006 
 - 135-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-3126 
<br/><br/><label>Standard No.: </label>10.1159/000092518  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Chronic Disease<br/>Enzyme Activation--drug effects<br/>Female<br/>Guanylate Cyclase--metabolism<br/>Hypertension, Pulmonary--drug therapy<br/>Hypertrophy, Right Ventricular--pathology<br/>Hypoxia--complications<br/>Lung--blood supply<br/>Organ Size<br/>Pregnancy<br/>Pulmonary Artery--drug effects<br/>Pyrazoles--pharmacology<br/>Pyridines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Vasodilation--drug effects